Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
UTI Healthcare Fund-Reg(G)
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesEQ - SUN PHARMACEUTICALS INDUSTRIES10.0816661016110.7665
Domestic EquitiesEQ - CIPLA LTD.5.482540000060.2360
Domestic EquitiesEQ - AJANTA PHARMA LTD.4.920021000054.0561
Domestic EquitiesEQ - PROCTOR & GAMBLE HEALTH LTD4.29698028347.2104
Domestic EquitiesEQ - DR REDDYS LABORATORIES LTD.4.204836000046.1988
Domestic EquitiesEQ - GLENMARK PHARMACEUTICALS LTD.3.990625000043.8450
Domestic EquitiesEQ - LUPIN LTD.3.527820000038.7600
Domestic EquitiesEQ - APOLLO HOSPITALS ENTERPRISE LT3.49345300038.3826
Domestic EquitiesEQ - DIVIS LABORATORIES LTD.3.47075600038.1332
Domestic EquitiesEQ - FORTIS HEALTHCARE LTD.3.362546500036.9443
Domestic EquitiesEQ- JUPITER LIFE LINE HOSPITALS LTD3.066322500033.6893
Domestic EquitiesEQ - GLAND PHARMA LTD.3.004018000033.0048
Domestic EquitiesEQ - COHANCE LIFESCIENCES LIMITED2.806831861130.8384
Domestic EquitiesEQ - MAX HEALTHCARE INSTITUTE LTD2.787324000030.6240
Domestic EquitiesEQ - ERIS LIFESCIENCES LTD2.745717915830.1666
Domestic EquitiesEQ - CAPLIN POINT LABORATORIES LTD2.730614167530.0011
Domestic EquitiesEQ - KRISHNA INSTITUTE OF MEDI SCIE2.638443035028.9884
Domestic EquitiesEQ - AUROBINDO PHARMA LTD.2.582125000028.3700
Domestic EquitiesEQ - ALKEM LABORATORIES LTD2.11704709423.2597
Domestic EquitiesEQ - ASTER DM HEALTHCARE LTD2.092338567522.9882
Domestic EquitiesEQ - IPCA LABORATORIES LTD.1.943315362821.3512
Domestic EquitiesEQ - MARKSANS PHARMA LTD.1.797075500019.7433
Domestic EquitiesEQ - SAI LIFE SCIENCES LTD1.779125271219.5473
Domestic EquitiesEQ- GLOBAL HEALTH LTD.1.601115474717.5916
Domestic EquitiesEQ - METROPOLIS HEALTHCARE LTD1.552910000017.0620
Domestic EquitiesEQ - SEQUENT SCIENTIFIC LTD1.528387114516.7913
Domestic EquitiesEQ - PFIZER LIMITED1.51902939616.6896
Domestic EquitiesEQ - WINDLAS BIOTEC LTD1.301316050714.2972
Domestic EquitiesEQ - VIJAYA DIAGNOSTIC CENTRE LTD1.255414000013.7935
Domestic EquitiesEQ - SANOFI CONSUMER HEALTHCARE INDIA LTD1.23342379213.5519
Domestic EquitiesEQ - BIOCON LTD.1.226337878813.4735
Domestic EquitiesEQ - TORRENT PHARMACEUTICALS LTD.1.18193810112.9856
Domestic EquitiesEQ - RAINBOW CHILDRENS MEDICARE LTD1.17278249012.8849
Domestic EquitiesEQ - SYNGENE INTERNATIONAL LTD.1.046718000011.5002
Domestic EquitiesEQ - ALEMBIC PHARMACEUTICALS1.034210935011.3626
Domestic EquitiesEQ - JUBILANT PHARMOVA LIMITED0.98818967510.8561
Domestic EquitiesEQ - LAXMI DENTAL LIMITED0.931623560710.2359
Domestic EquitiesEQ - ACUTAAS CHEMICALS LIMITED0.92948922410.2108
Domestic EquitiesEQ - EMCURE PHARMACEUTICALS LTD0.8243700009.0566
Domestic EquitiesEQ - ORCHID PHARMA LTD.0.65011000007.1430
Total 98.8977 1086.5915
Cash & Cash Equivalents and Net AssetsNET CURRENT ASSETS1.0923 12.0014
Total 1.0923 12.0014
Deposits (Placed as Margin)CLEARING CORPORATION OF INDIA LTD. STD - MARGIN0.010000.1100
Total 0.0100 0.1100
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.